The impact of a physician-staffed helicopter on outcome in patients admitted to a stroke unit: A prospective observational study

Abstract

Background: Transportation by helicopter may reduce time to hospital admission and improve outcome. We aimed to investigate the effect of transport mode on mortality, disability, and labour market affiliation in patients admitted to the stroke unit. Methods: Prospective, observational study with 5.5years of follow-up. We included patients admitted to the stroke unit the first three years after implementation of a helicopter emergency medical services (HEMS) from a geographical area covered by both the HEMS and the ground emergency medical services (GEMS). HEMS patients were compared with GEMS patients. Primary outcome was long-term mortality after admission to the stroke unit. Results: Of the 1679 patients admitted to the stroke unit, 1068 were eligible for inclusion. Mortality rates were 9.04 per 100 person-years at risk (PYR) in GEMS patients and 9.71 per 100 PYR in HEMS patients (IRR=1.09, 95% CI 0.79-1.49; p=0.60). The 30-day mortality was 7.4% with GEMS and 7.9% with HEMS (OR=1.02, CI 0.53-1.96; p=0.96). Incidence rate of involuntary early retirement was 6.97 per 100 PYR and 7.58 per 100 PYR in GEMS and HEMS patients, respectively (IRR=1.19, CI 0.27-5.26; p=0.81). Work ability after 2years and time on social transfer payments did not differ between groups. We found no significant difference in mean modified Rankin Scale score after 3months (2.21 GEMS vs. 2.09 HEMS; adjusted mean difference=-0.20, CI -0.74-0.33; p=0.46). Discussion: The possible benefit of HEMS for neurological outcome isprobably difficult todetect by considering mortality, but for the secondary analyses we had less statistical poweras illustrated by the wide confidence intervals. Conclusion: Helicopter transport of stroke patients was not associated with reduced mortality or disability, nor improved labour market affiliation compared to patients transported by a ground unit. Trial registration: The study was registered at ClinicalTrials.gov (NCT02576379).